Clinical effects of treatment for hypogonadism in male adolescents with Prader-Labhart-Willi syndrome

Hormone Research

Volumn 68, Issue 4, 2007, Pages 178-184

  Eiholzer, Urs ^a   Grieser, Jürgen ^a   Schlumpf, Michael ^a   L'Allemand, Dagmar ^a  

^a Institute Growth Puberty Adolescence   (Switzerland)

Author keywords

Body composition; Fat mass; Human chorionic gonadotropin therapy; Hypogonadism; Lean mass; Prader Labhart Willi syndrome; Puberty

Indexed keywords

CHORIONIC GONADOTROPIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; TESTOSTERONE;

ADOLESCENT; AGGRESSION; ARTICLE; BEHAVIOR CHANGE; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; BONE AGE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; GROWTH DISORDER; HUMAN; HYPOGONADISM; LONG TERM CARE; MALE; MENTAL INSTABILITY; MUSCLE MASS; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SOCIAL INTERACTION; TESTIS; TESTOSTERONE BLOOD LEVEL; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; DRUG EFFECT; FOLLOW UP;

ADOLESCENT; ADOLESCENT BEHAVIOR; BODY COMPOSITION; CHILD; CHORIONIC GONADOTROPIN; FOLLOW-UP STUDIES; HUMANS; HYPOGONADISM; MALE; PRADER-WILLI SYNDROME; PUBERTY;

EID: 35248881204     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100925     Document Type: Article

References (49)

1. Eiholzer U: Prader-Willi Syndrome. Effects of Human Growth Hormone Treatment. Basel, Karger, 2001.
2. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB: The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 2001;108:E92.
3. Eiholzer U, Bachmann S, l'Allemand D: Is there a growth hormone deficiency in Prader-Willi syndrome? Six arguments to support the presence of a hypothalamic growth hormone deficiency in Prader-Willi syndrome. Horm Res 2000;53(suppl 3):44-52.
4. Prader A, Willi H: Das Syndrom von Imbezibilität, Adipositas, Muskelhypotonie, Hypogenitalismus, Hypogonadismus und Diabetes mellitus mit 'Myatonie'-Anamnese. 2nd Int Congr Ment Retard, Vienna, 1961, pp 353-357.
5. Grugni G, Morabito F, Crino A: Gonadal function and its disorders in simple obesity and in Prader-Willi syndrome; in Eiholzer U, l'Allemand D, Zipf W (eds): Prader-Willi Syndrome as a Model for Obesity. Basel, Karger, 2003, pp 140-155.
6. Eiholzer U, l'Allemand D, Rousson V, Schlumpf M, Gasser T, Girard J, Grüters A, Simoni M: Hypothalamic and gonadal components of hypogonadism in boys with Prader-Labhart-Willi syndrome. J Clin Endocrinol Metab 2006;91:892-898.
7. Davies PS, Joughin C: Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome. Am J Ment Retard 1993;98:349-353.
8. Eiholzer U, Nordmann Y, l'Allemand D, Schlumpf M, Schmid S, Kromeyer-Hauschild K: Improving body composition and physical activity in Prader-Willi Syndrome. J Pediatr 2003;142:73-78.
9. Holland AJ, Treasure J, Coskeran P, Dallow J: Characteristics of the eating disorder in Prader-Willi syndrome: implications for treatment. J Intellect Disabil Res 1995;39:373-381.
10. Lindgren AC, Barkeling B, Hagg A, Ritzen EM, Marcus C, Rossner S: Eating behavior in Prader-Willi syndrome, normal weight, and obese control groups. J Pediatr 2000;137:50-55.
11. Hinton E, Holland A, Gellatly M, Soni S, Patterson M, Ghatei M, Owen A: Neural representations of hunger and satiety in Prader-Willi syndrome. Int J Obes (Lond) 2006;30:313-321.
12. Eiholzer U, l'Allemand D, van der Sluis I, Steinert H, Ellis K: Body composition abnormalities in children with Prader-Willi syndrome and long-term effects of growth hormone therapy. Horm Res 2000;53:200-206.
13. van Mil EA, Westerterp KR, Gerver WJ, Curfs LM, Schrander-Stumpel CT, Kester AD, Saris WH: Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. Am J Clin Nutr 2000;71:752-756.
14. Eiholzer U, Blum WF, Molinari L: Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. J Pediatr 1999;134:222-225.
15. Eiholzer U, l'Allemand D, Schlumpf M, Rousson V, Gasser T, Fusch C: Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome. J Pediatr 2004;144:753-758.
16. Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB: Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr 2004;145:744-749.
17. Eiholzer U, Gisin R, Weinmann C, Kriemler S, Steinert H, Torresani T, Zachmann M, Prader A: Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. Eur J Pediatr 1998;157:368-377.
18. Eiholzer U, l'Allemand D: Growth hormone normalises height, prediction of final height and hand length in children with Prader-Willi syndrome after four years of therapy. Horm Res 2000;53:185-192.
19. Eiholzer U, Whitman BY: A comprehensive team approach to the management of patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 2004;17:1153-1175.
20. Schlumpf M, Eiholzer U, Gygax M, Schmid S, van der Sluis I, l'Allemand D: A daily comprehensive muscle training programme increases lean mass and spontaneous activity in children with Prader-Willi syndrome after 6 months. J Pediatr Endocrinol Metab 2006;19:65-74.
21. Bray G, Dahms W, Swerdloss R, Fiser R, Atkinson R, Carrel X: The Prader-Willi syndrome. A study of 40 patients and a review of the literature. Medicine 1983;62:59-80.
22. Wollmann HA, Schultz U, Grauer M, Ranke M: Reference values for height and weight in Prader-Willi syndrome based on 315 patients. Eur J Pediatr 1998;157:634-642.
23. Schoeller D, Levitsky L, Bandini L, Dietz W, Walczak A: Energy expenditure and body composition in Prader-Willi syndrome. Metabolism 1988;37:115-120.
24. Lindgren AC, Hagenas L, Ritzen EM: Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Horm Res 1999;51:157-161.
25. l'Allemand D, Eiholzer U, Schlumpf M, Torresani T, Girard J: The carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Horm Res 2003;59:239-248.
26. Ritzen EM: Endocrine physiology and therapy in Prader-Willi syndrome; in Cassidy SB (ed): Prader-Willi Syndrome and Other Chromosome 15q Deletion Disorders. New York, Springer, 1992, pp 153-169.
27. Crino A, Schiaffini R, Ciampalini P, Spera S, Beccaria L, Benzi F, Bosio L, Corrias A, Gargantini L, Salvatoni A, Tonini G, Trifiro G, Livieri C: Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr 2003;162:0327-333.
28. Dykens EM, Leckman JF, Cassidy SB: Obsessions and compulsions in Prader-Willi syndrome. J Child Psychol Psychiatry 1996;37:995-1002.
29. Dimitropoulos A, Feurer ID, Roof E, Stone W, Butler MG, Sutcliffe J, Thompson T: Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome. Ment Retard Dev Disabil Res Rev 2000;6:125-130.
30. Dykens EM, Hodapp RM, Walsh K, Nash LJ: Profiles, correlates, and trajectories of intelligence in Prader-Willi syndrome. J Am Acad Child Adolesc Psychiatry 1992;31:1125-1130.
31. Clarke DJ, Boer H, Whittington J, Holland A, Butler J, Webb T: Prader-Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry 2002;180:358-362.
32. Boer H, Holland A, Whittington J, Butler J, Webb T, Clarke D: Psychotic illness in people with Prader Willi syndrome due to chromosome 15 maternal uniparental disomy. Lancet 2002;359:135-136.
33. Vogels A, De Hert M, Descheemaeker MJ, Govers V, Devriendt K, Legius E, Prinzie P, Fryns JP: Psychotic disorders in Prader-Willi syndrome. Am J Med Genet A 2004;127:238-243.
34. Steinhausen HC, Eiholzer U, Hauffa BP, Malin Z: Behavioural and emotional disturbances in people with Prader-Willi syndrome. J Intellect Disabil Res 2004;48:47-52.
35. Prader A, Largo R, Molinari L, Issler C: Physical growth of Swiss children from birth to 20 years of age. Helv Paediatr Acta Suppl 1989;52:1-125.
36. Greulich W, Pyle S: Radiographic Atlas of the Development of the Hand and Wrist. Stanford, Stanford University Press, 1959.
37. Boot AM, Bouquet J, de Ridder MA, Krenning EP, De Muinck K: Determinants of body composition measured by dual-energy X-ray absorptiometry in Dutch children and adolescents. Am J Clin Nutr 1997;66:232-238.
38. l'Allemand D, Eiholzer U, Schlumpf M, Steinert H, Riesen W: Cardiovascular risk factors improve under 3 years of growth hormone therapy in Prader-Willi syndrome. Eur J Pediatr 2000;159:835-842.
39. l'Allemand D, Eiholzer U, Rousson V, Girard J, Blum WF, Torresani T, Gasser T: Increased adrenal androgens in Prader-Willi syndrome are associated with insulin, IGF-I and leptin, but not with measures of obesity. Horm Res 2002;58:215-222.
40. Zachmann M: Evaluation of gonadal function in childhood and adolescence. Helv Paediatr Acta 1974;suppl 34:53-62.
41. Carrel AL, Myers SE, Whitman BY, Allen DB: Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab 2002;87:1581-1585.
42. Dykens EM, Cassidy SB: Prader-Willi syndrome. Genetic, behavioural and treatment issues. Child Adolesc Psychiatr Clin N Am 1996;5:193-927.
43. Steinhausen HC, Eiholzer U, Hauffa BP, Malin Z: Behavioural and emotional disturbances in people with Prader-Willi syndrome. J Intellect Disabil Res 2004;48:47-52.
44. Burd L, Vesely B, Martsolf J, Korbeshian J: Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet 1990;37:97-99.
45. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H: Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet 2001;38:792-798.
46. Bourguignon JP: Linear growth as a function of age at onset of puberty and sex steroid dosage: therapeutic implications. Endocr Rev 1988;9:467-488.
47. Pope HG Jr, Kouri EM, Hudson JI: Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial. Arch Gen Psychiatry 2000;57:133-140.
48. Weiss EL, Bowers MB Jr, Mazure CM: Testosterone-patch-induced psychotic mania. Am J Psychiatry 1999;156:969.
49. Hartgens F, Kuipers H: Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:513-554.